ERBB2 and breast carcinoma: We identified a global miRNA profile using a panel of breast cancer cell lines from luminal (MCF-7, MCF-7/AZ and T47D), HER2 overexpressed (BT-20 and SKBR3), triple negative subtypes (MDA-MB-231 and Hs578T) and normal epithelial breast cancer cell line (HB4A).